文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒性休克患者液体负荷后评估时间的选择

[Choice of assessment time after fluid challenge in patients with septic shock].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2019-01-01
一句话结论脓毒性休克液体负荷后,胶体组液体反应性评估可延长至30分钟,晶体组可在10分钟评估,作者认为评估时机应个体化。

该前瞻性观察研究纳入2016年7月至2018年12月北京协和医院内科ICU收治的40例肺动脉导管监测的脓毒性休克患者,按主治医师选择分为晶体组(生理盐水500 mL)和胶体组(4%琥珀酰明胶500 mL),各20例。液体反应性定义为液体负荷后心脏指数(CI)增加超过10%。胶体组CI在30分钟达最大(76.7±18.3 mL×s⁻¹×m⁻²),60分钟时仍观察到CI增加≥10%;晶体组CI在10分钟达最大(73.3±28.3 mL×s⁻¹×m⁻²),60分钟降至基线,10分钟时观察到CI增加≥10%。作者认为胶体组评估时间可延长至液体负荷后30分钟,晶体组可在10分钟评估。

要点

  • 脓毒性休克患者液体负荷后,胶体组(4%琥珀酰明胶500 mL)液体反应性评估时间可延长至30分钟,晶体组(生理盐水500 mL)可在10分钟评估(作者认为)。
  • 液体反应性定义为液体负荷后CI增加超过10%;40例中26例为液体反应者(胶体组12例、晶体组14例),14例无反应者(胶体组8例、晶体组6例)。
  • 胶体组CI在液体负荷后30分钟达最大(76.7±18.3 mL×s⁻¹×m⁻²),60分钟时仍观察到CI增加≥10%;晶体组CI在10分钟达最大(73.3±28.3 mL×s⁻¹×m⁻²),60分钟降至基线。
  • 反应者中,胶体组CI增加≥10%持续至液体负荷后120分钟,晶体组仅持续至30分钟;两组CI变化在30、45、60、90分钟差异有统计学意义。
  • 胶体组CVP和PAWP在液体负荷后120分钟内均显著高于负荷前,晶体组仅10分钟时高于负荷前;胶体组MAP在液体负荷结束即刻达最大、45分钟降至基线,晶体组MAP及两组HR在120分钟内无差异。

适用人群与场景

  • 2016年7月至2018年12月北京协和医院内科ICU收治的脓毒性休克患者,均置入肺动脉导管监测。
  • 所有纳入患者均接受液体负荷,液体类型由主治医师选择:晶体组为生理盐水500 mL,胶体组为4%琥珀酰明胶500 mL。

诊断标准与关键阈值

  • 液体反应性定义为液体负荷后心脏指数(CI)增加超过10%。

处置流程与药物剂量

  • 晶体组:生理盐水500 mL液体负荷,液体负荷后10分钟评估液体反应性(CI增加≥10%在此时间点观察到)。
  • 胶体组:4%琥珀酰明胶500 mL液体负荷,液体负荷后30分钟评估液体反应性(CI在此时间点达最大),评估时间可延长至30分钟(作者认为)。
  • 液体负荷后监测时间点:基线及液体负荷后0(即刻)、10、30、45、60、90、120分钟,监测CI、HR、MAP、CVP、PAWP。

研究设计与关键结果

  • 前瞻性观察研究,纳入40例脓毒性休克患者,晶体组和胶体组各20例;液体反应者26例(胶体组12例、晶体组14例),无反应者14例(胶体组8例、晶体组6例)。
  • 与液体负荷前相比,晶体组和胶体组CI均显著升高(71.7±16.7 vs. 65.0±16.7,68.3±25.0 vs. 63.3±23.3 mL×s⁻¹×m⁻²,均P<0.05)。
  • 胶体组CI在液体负荷后30分钟达最大(76.7±18.3 mL×s⁻¹×m⁻²),120分钟时仍显著高于负荷前(70.0±16.7 mL×s⁻¹×m⁻²,P<0.05),60分钟时观察到CI增加≥10%;晶体组CI在10分钟达最大(73.3±28.3 mL×s⁻¹×m⁻²),60分钟降至基线,10分钟时观察到CI增加≥10%。
  • 液体负荷后不同时间点两组CI变化无显著差异;无反应者CI随时间无变化,反应者CI随时间升高。
  • 反应者中,胶体组CI增加≥10%持续至液体负荷后120分钟,晶体组持续至30分钟;两组CI变化在液体负荷后30、45、60、90分钟差异有统计学意义(18.3±3.3 vs. 8.3±1.7,18.3±3.3 vs. 5.0±1.7,13.3±1.7 vs. 3.3±1.7,11.7±3.3 vs. 3.3±1.7 mL×s⁻¹×m⁻²,均P<0.05)。
  • CVP和PAWP最大值均在液体负荷结束时;胶体组两变量在120分钟内均显著高于负荷前,晶体组仅10分钟时高于负荷前;胶体组MAP在液体负荷结束即刻达最大、45分钟降至基线,晶体组MAP及两组HR在120分钟内无差异。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,脓毒性休克患者液体负荷后,胶体组液体反应性评估时间可延长至30分钟,晶体组可在10分钟评估,评估时机应个体化。
  • 使用4%琥珀酰明胶500 mL行液体负荷时,CI增加≥10%可持续至120分钟,而生理盐水500 mL时仅持续至30分钟(反应者中),提示晶体组需更早评估。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the short-term hemodynamic change of fluid challenge (FC) with crystalloid or colloid and define fluid responsiveness at the optimal time in patients with septic shock.

METHODS: A prospective observational study was conducted. Septic shock patients monitored with pulmonary catheters admitted to medical intensive care unit (ICU) of the Peking Union Medical College Hospital from July 2016 to December 2018 were enrolled. All included patients received FC and were divided into two groups according to the type of fluid used, i.e. crystalloid group (normal saline for 500 mL) and colloid group (4% succinyl gelatin for 500 mL). The choice of fluid type was decided by the attending physician. Hemodynamic variables were measured at baseline, and 0 (immediately), 10, 30, 45, 60, 90, 120 minutes after FC, included cardiac index (CI), heart rate (HR), mean artery pressure (MAP), central venous pressure (CVP) and pulmonary arterial wedge pressure (PAWP). Fluid responsiveness was defined as CI increased by more than 10% after FC. The data were analyzed by repeated measurements of variance between the two groups as well as responders and nonresponders.

RESULTS: Forty patients were included, 20 cases each in colloid group and crystalloid group; of whom 26 were fluid responders with 12 of colloid group and 14 of crystalloid group. Of the 14 nonresponders, 8 were of colloid group and 6 of crystalloid group. (1) Compared with before FC, CI (mL×s-1×m-2) was significantly increased in crystalloid and colloid groups after FC (71.7±16.7 vs. 65.0±16.7, 68.3±25.0 vs. 63.3±23.3, both P < 0.05). In the colloid group, volume expansion increased the CI to maximum (76.7±18.3) at 30 minutes after FC, at 120 minutes after FC, a significantly higher CI (70.0±16.7) was also observed (P < 0.05), an increased in CI ≥ 10% was observed at 60 minutes after FC. In the crystalloid group, CI was increased to maximum at 10 minutes (73.3±28.3) and decreased to baseline at 60 minutes, an increased in CI ≥ 10% was also observed at 10 minutes after FC. In addition, there was no significant difference in CI changes between colloidal group and crystalloid group at different time points after FC. (2) CI did not change over time in nonresponders groups, whereas in responders CI increased parallelly to that in both crystalloid and colloid groups over time. However, an increased in CI ≥ 10% was observed through the 120 minutes after FC in responders of colloid group compared with that of at 30 minutes after FC in crystalloid group. There was significant difference in CI changes between colloidal group and crystalloid group at 30, 45, 60, 90 minutes after FC (mL×s-1×m-2: 18.3±3.3 vs. 8.3±1.7, 18.3±3.3 vs. 5.0±1.7, 13.3±1.7 vs. 3.3±1.7, 11.7±3.3 vs. 3.3±1.7, all P < 0.05). (3) The maximal values of CVP and PAWP were observed at the end of FC. In colloid group, both the two variables were notably higher than that before FC over 120 minutes compared with that of only at 10 minutes in crystalloid group. The MAP in colloid increased to maximum immediately at the end of FC and decreased to baseline at 45 minutes, however, the MAP in crystalloid group and HR of both groups showed no differences over 120 minutes.

CONCLUSIONS: Hemodynamic changes were significantly different between crystalloid and colloid after FC in patients with septic shock. Therefore, the timing of fluid responsiveness assessment should be different individually. The assessment time of colloid group may be prolonged to 30 minutes after FC while that of crystal group can be at 10 minute after FC.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Huang H, Liu G, Xu B, et al. [Choice of assessment time after fluid challenge in patients with septic shock]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31109411. doi:10.3760/cma.j.issn.2095-4352.2019.04.007

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。